RAVIKIRTI et al. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. Journal of Pharmacy & Pharmaceutical Sciences, [S. l.], v. 24, n. 3, p. 343–350, 2021. DOI: 10.18433/jpps32105. Disponível em: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32105. Acesso em: 20 apr. 2024.